Abstract
Many chronic diseases are associated with a significantly increased risk of depression (Gold et al. 2020). In particular, patients with cardiometabolic and neurological diseases have a point prevalence of major depressive disorder (MDD) of 25–35%. Thus, the risk of being diagnosed with MDD is three to four times higher in these groups than in the general population, where the point prevalence of MDD is estimated around 5–7% in most industrialized countries (Otte et al. 2016).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aikens JE, Reinecke MA, Pliskin NH, Fischer JS, Wiebe JS, et al. Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original beck depression inventory? J Behav Med. 1999;22(2):127–42.
Binzer S, McKay KA, Brenner P, Jan Hillert J, Manouchehrinia A. Disability worsening among persons with multiple sclerosis and depression. Neurology. 2019;9:e2216–23.
Boeschoten RE, Braamse AMJ, Beekman ATJ, Cuijpers P, van Oppen P, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.
Erlangsen A, Egon S, Conwell Y, Andersen PK, Hawton K, et al. Association between neurological disorders and death by suicide in Denmark. JAMA. 2020;323:444–54.
Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10(9):507–17.
Fischer A, Fischer M, Nicholls RA, Lau S, Pöttgen J, et al. Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav. 2015a;5(9):e00365.
Fischer A, Schröder J, Vettorazzi E, Wolf OT, Pöttgen J, et al. An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. Lancet Psychiatry. 2015b;2(3):217–23.
Fragoso YD, Adoni T, Anacleto A, da Gama PD, MVM G, et al. Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. Pract Neurol. 2014;14(4):206–9.
Gold SM, Kern KC, O’Connor M-F, Montag MJ, Kim A, Yoo YS, et al. Smaller cornu ammonis 2-3 / dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry. 2010;68(6):553–9.
Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda IJ, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020;6(1):69.
Gold SM, Krüger S, Ziegler KJ, Krieger T, Schulz K-H, et al. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J Neurol Neurosurg Psychiatry. 2011;82:814–8.
Gold SM, O’Connor M-F, Gill R, Kern KC, Shi Y, et al. Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling. Hum Brain Mapp. 2014;35(1):30–7.
Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, et al. Characterizing the phenotype of multiple sclerosis-associated depression in comparison to idiopathic major depression. Mult Scler. 2016;22(11):1476–84.
Marrie RA. Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol. 2017;13:375–82.
McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018;90:e1316–23.
Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC ... Narayanaswami P. Guideline development subcommittee of the american academy of neurology. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the guideline development subcommittee of the american academy of neurology. Neurology. 2014;82:174–81.
Mohr DC, Hart SL, Fonareva I, Tasch ES. Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006;12(2):204–8.
Mohr DC, Hart SL, Julian L, Tasch ES. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler. 2007;13(2):215–9.
Otte C, Gold SM, Pennix BR, Pariante CM, Etkin A, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065. https://doi.org/10.1038/nrdp.2016.65.
Patten SB, Burton JM, Fiest KM, Wiebe S, Bulloch AGM, et al. Validity of four screening scales for major depression in MS. Mult Scler. 2015;21(8):1064–71.
Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017;13(11):662–75.
Pöttgen J, Moss-Morris R, Wendebourg J-M, Feddersen L, Lau S, et al. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(9):970–6.
Acknowledgments
Deutsche Forschungsgemeinschaft (DFG), National MS Society (NMSS), Bundesgesundheitsministerium (BMG).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gold, S.M. (2023). Fatigue and Depression. In: Penner, IK. (eds) Fatigue in Multiple Sclerosis. Springer, Cham. https://doi.org/10.1007/978-3-031-13498-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-13498-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13497-5
Online ISBN: 978-3-031-13498-2
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)